Aperto Finanziamento europeo

European Partnership for Pandemic Preparedness (Phase 2)

Erogato da Commissione Europea

Descrizione

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. Proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: The EU offers a valued operational network of clinical research sites (both interventional and observational) that have the capacity to implement well-coordinated large-scale multi-country quality clinical studies in different target populations, which are able to smoothly transition to interventions relevant for cross-border health threats in readiness for or response to a public health emergency. Key stakeholders, including relevant EU and national entities, the scientific communities, policymakers and funders enhance their collaboration and coordination to strengthen research on pandemic preparedness and response, forming a strong, structured and comprehensive ecosystem with shared evidence, tools and methodologies cutting across sectors. Research funders, policymakers, relevant EU and national entities, and the research community recognise and rapidly close relevant research and related infrastructure gaps and break existing silos on pandemic preparedness research and response, adopting a One Health approach. Healthcare authorities, regulatory authorities, policymakers and other stakeholders utilise research results to develop…

Beneficiari

Imprese Università Enti di ricerca PMI

Settori

Programme Cofund Actions Basic medicine Clinical Pharmacology Clinical research Clinical trials Cohort studies Drug development, clinical phases Drug development, late phases

Ambito territoriale

Unione Europea Nazionale

Tematiche

2021 2027